Reduction of Influenza A Virus Transmission in Mice by a Universal Intranasal Vaccine Candidate is Long-Lasting and Does Not Require Antibodies.

MLA

Price, Graeme E., et al. “Reduction of Influenza A Virus Transmission in Mice by a Universal Intranasal Vaccine Candidate Is Long-Lasting and Does Not Require Antibodies.” Journal of Virology, vol. 96, no. 12, June 2022, pp. 1–16. EBSCOhost, https://doi.org/10.1128/jvi.00320-22.

APA

Price, G. E., Chia-Yun Lo, Misplon, J. A., & Epstein, S. L. (2022). Reduction of Influenza A Virus Transmission in Mice by a Universal Intranasal Vaccine Candidate is Long-Lasting and Does Not Require Antibodies. Journal of Virology, 96(12), 1–16. https://doi.org/10.1128/jvi.00320-22

Chicago

Price, Graeme E., Chia-Yun Lo, Julia A. Misplon, and Suzanne L. Epstein. 2022. “Reduction of Influenza A Virus Transmission in Mice by a Universal Intranasal Vaccine Candidate Is Long-Lasting and Does Not Require Antibodies.” Journal of Virology 96 (12): 1–16. doi:10.1128/jvi.00320-22.